Palacios, Santiago <br/><br/>
Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Mar 2015 
 - E487-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2014-3594  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Denosumab<br/>Diphosphonates--therapeutic use<br/>Drug Substitution<br/>Etidronic Acid--analogs & derivatives<br/>Female<br/>Humans<br/>Ibandronic Acid<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Patient Satisfaction<br/>Risedronic Acid<br/>Treatment Outcome<br/>Assessment of Medication Adherence